These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23940135)

  • 1. Clinical significance of micropapillary urothelial carcinoma of the upper urinary tract.
    Sung HH; Cho J; Kwon GY; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    J Clin Pathol; 2014 Jan; 67(1):49-54. PubMed ID: 23940135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
    Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
    BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
    Fritsche HM; Novara G; Burger M; Gupta A; Matsumoto K; Kassouf W; Sircar K; Zattoni F; Walton T; Tritschler S; Baba S; Bastian PJ; Martínez-Salamanca JI; Seitz C; Otto W; Wieland WF; Karakiewicz PI; Ficarra V; Hartmann A; Shariat SF
    Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of p63, p40, and GATA-binding protein 3 immunohistochemistry in diagnosing micropapillary urothelial carcinoma.
    Lin X; Zhu B; Villa C; Zhong M; Kundu S; Rohan SM; Yang XJ
    Hum Pathol; 2014 Sep; 45(9):1824-9. PubMed ID: 24993315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.
    Grasso M; Fishman AI; Cohen J; Alexander B
    BJU Int; 2012 Dec; 110(11):1618-26. PubMed ID: 22458598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
    Hurel S; Rouprêt M; Ouzzane A; Rozet F; Xylinas E; Zerbib M; Berod AA; Ruffion A; Adam E; Cussenot O; Houlgatte A; Phé V; Nouhaud FX; Bensadoun H; Delage F; Guillotreau J; Guy L; Karsenty G; De La Taille A; Colin P;
    BJU Int; 2013 Jun; 111(8):1199-207. PubMed ID: 23650914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
    Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic values of the clinicopathological characteristics and survival outcomes in micropapillary urothelial carcinoma of the bladder: A SEER database analysis.
    Jin D; Jin K; Qiu S; Zhou X; Yuan Q; Yang L; Wei Q
    Cancer Med; 2020 Jul; 9(14):4897-4906. PubMed ID: 32529761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine cytomorphology of micropapillary urothelial carcinoma.
    Zhu B; Rohan SM; Lin X
    Diagn Cytopathol; 2013 Jun; 41(6):485-91. PubMed ID: 22623512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
    Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
    Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.
    Walton TJ; Sherwood BT; Parkinson RJ; Obakponovwe O; Thomas SA; Taylor MC; England RC; Lemberger RJ
    J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours.
    Bin X; Roy OP; Ghiraldi E; Manglik N; Liang T; Vira M; Kavoussi LR
    BJU Int; 2012 Dec; 110(11 Pt B):E514-9. PubMed ID: 22578024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic Analysis of Micropapillary Urothelial Carcinoma of the Upper Urinary Tract: Implications for HER2-Targeted Therapy.
    Chou LP; Hsu CW; Yang SF; Lee CT; Ou YC; Lin KC; Hu CY; Jou YC; Tsai YS; Chow NH
    Clin Genitourin Cancer; 2023 Aug; 21(4):508.e1-508.e10. PubMed ID: 37183125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micropapillary urothelial carcinoma of the renal pelvis: report of a case and review of the literature.
    Munakata S; Tahara H; Kojima K; Kishimoto T
    Med Sci Monit; 2007 Apr; 13(4):CS47-52. PubMed ID: 17392655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micropapillary variant of urothelial carcinoma: a report of 4 cases and literature review.
    Cheng YT; Luo HL; Sung MT; Chiang PH
    Chang Gung Med J; 2010; 33(4):461-5. PubMed ID: 20804677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphovascular invasion in micropapillary urothelial carcinoma: a study of 22 cases.
    McQuitty E; Ro JY; Truong LD; Shen SS; Zhai Q; Ayala AG
    Arch Pathol Lab Med; 2012 Jun; 136(6):635-9. PubMed ID: 22646270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy.
    Youssef RF; Shariat SF; Lotan Y; Cost N; Wood CG; Sagalowsky AI; Zigeuner R; Langner C; Chromecki TF; Montorsi F; Bolenz C; Margulis V
    Urol Oncol; 2013 Jul; 31(5):676-81. PubMed ID: 21704538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.